Cancer News and Research

Latest Cancer News and Research

Australian collaboration to produce cancer immunotherapy vaccines

A Brisbane based biomedical company, Tissue Therapies Limited (TIS) and the Queensland Institute of Medical Research (QIMR) have agreed on the terms of a new collaboration aimed at developing Tissue Therapies' VitroGro® cell growth technology as a platform to produce cancer immunotherapy vaccines.

21 Jul 2004

Unique dual laparoscopic surgical procedure

The skill and teamwork of two physicians at Scripps Clinic, combined with the expertise of the surgical staff at Scripps Green Hospital, recently led to a unique surgery that changed the life of a local woman.

21 Jul 2004

Psychotherapist offering equine-assisted psychotherapy

Psychotherapists employ a variety of methods to aid in their patients’ recovery, ranging from conversation to medication to hypnosis to horses. Yes - horses!

21 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

European funding to study how yeasts such as Candida cause infections among hospital patients

Dr Fritz Mühlschlegel, Reader in Medical Microbiology in the Biosciences Department at Kent and Consultant Medical Microbiologist in the East Kent NHS Trust, and Dr Daniel Poullain from Lille’s Medical School have been awarded 315,106 euros under the EU’s Interreg Programme to study the mechanisms by which fungal pathogens cause disease.

21 Jul 2004

Test that is 100% effective in detection of early ovarian cancer

The journal Endocrine-Related Cancer has published work showing that scientists from the Clinical Proteomics Program of the US National Cancer Institute (NCI) have discovered a test that was 100% effective for detecting early ovarian cancer in their study.

21 Jul 2004

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.

21 Jul 2004

New book predicts a "vaccine century"

A new book published by the Pan American Health Organization (PAHO) predicts that the 21st century will become the "century of vaccines" thanks to rapid developments in the field of immunization.

21 Jul 2004

Chemotherapy and supportive care are a winning combination

Gastrointestinal cancer, including colorectal, is one of the most common groups of cancers to claim Western lives.

21 Jul 2004

Chemotherapy aimed at both cancer cells and their genetically normal cellular 'microenvironment' might improve the success of breast cancer treatment

In the first comprehensive survey of gene activity in each cell type composing normal and malignant breast tissue, scientists at Dana-Farber Cancer Institute have identified genes in non-cancerous supporting cells that can spur the growth of breast cancer cells.

20 Jul 2004

Discovery challenges current thinking about how a cancer develops and spreads

When a physician discovers cancer in a patient, the first thing the doctor wants to know is whether that cancer has spread, or "metastasized."

20 Jul 2004

Recently amended draft Human Tissue Bill remains confused and will endanger the continuation of vital medical research

The Royal Society today warned the UK Government that the recently amended draft Human Tissue Bill remains confused and will endanger the continuation of vital medical research.

19 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

Cincinnati should go smoke-free

Cincinnati has just begun to consider strengthening its smoking restrictions. Anything short of protecting all workers' health would be just blowing smoke.

19 Jul 2004

First international server to analyze genetic diversity on a large scale

Researchers from the Universitat Autònoma de Barcelona have developed the first international server that allows the user to analyze genetic diversity on a large scale.

19 Jul 2004

Safer and improved technologies for detecting and treating scoliosis

Calgary researchers, healthcare providers and local patients are working together to develop a high-tech imaging system for detecting and treating of scoliosis – a mysterious spinal condition that affects about one out of every 200 people, especially children.

17 Jul 2004

New compound that is designed to overcome Gleevec resistance

One of the truly spectacular success stories in modern oncology is the development and implementation of Gleevec, a drug that virtually halts the progress of chronic myeloid leukemia. Yet for some patients who harbor particularly stubborn genetic mutations, Gleevec fails miserably.

17 Jul 2004

The cervical screening programme has saved Britain from an epidemic of cervical cancer

Cancer Research UK scientists estimate in a report published today that systematic cervical screening, introduced in 1988, is preventing up to 5,000 deaths a year from the disease in Britain.

16 Jul 2004

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

16 Jul 2004

Online database of AIDS-related protein structures

Researchers who are either developing drug treatments for AIDS or studying the virus that causes the disease have a new resource - an online database of AIDS-related protein structures just unveiled for public use by the National Institute of Standards and Technology.

16 Jul 2004